Study Finds Ciprofol Offers Safer Alternative to Propofol in Hysteroscopy Procedures
Hysteroscopy is a key tool in modern gynecology, allowing doctors to examine and treat uterine problems with minimal invasiveness. For patients, comfort and safety during this procedure are paramount. Traditionally, propofol has been the anesthetic of choice, but a new agent called ciprofol may offer important advantages, according to a recent;y published systematic review and meta-analysis.
Understanding the Study
Researchers analyzed six randomized controlled trials involving a total of 1,768 patients who underwent hysteroscopy. The main goal was to compare ciprofol and propofol in terms of how well they worked (efficacy) and how safe they were for patients. The studies focused on success rates for the procedure, how quickly patients fell asleep and woke up, and the frequency of side effects like pain at the injection site, low blood pressure, breathing problems, and unwanted movements during surgery.
Efficacy: Both Drugs Get the Job Done
The findings showed that both ciprofol and propofol were equally effective for hysteroscopy sedation. Every patient in these studies completed their procedure successfully, regardless of which sedative was used. The time it took to lose consciousness and recover was also very similar for both medications, meaning that switching to ciprofol shouldn’t slow down busy clinics.
Safety: Ciprofol Has the Edge
Where ciprofol really stood out was in its safety profile. Patients receiving ciprofol experienced:
Much less pain during injection
Lower rates of low blood pressure (hypotension)
Fewer breathing difficulties (hypoxemia)
Similar or fewer involuntary body movements
For patients who are older or have existing health concerns, these differences can be significant. Fewer complications mean less stress for both patients and clinicians, and potentially smoother procedures overall.
Why Does This Matter?
Choosing the right sedative isn’t just about getting through the procedure—it’s about patient experience and safety. Reduced pain and fewer side effects can make hysteroscopy less daunting, improve satisfaction, and help patients recover faster. For clinicians, a sedative with fewer risks may give more confidence—especially when treating those with underlying health conditions.
The Bottom Line
This new research suggests that ciprofol is just as effective as propofol for hysteroscopy sedation, but with added safety benefits. While more studies are needed, especially in higher-risk groups, ciprofol could soon become the preferred choice for both doctors and patients.
5 Key Takeaways
Ciprofol and propofol are equally effective for sedation during hysteroscopy.
Ciprofol significantly reduces injection pain compared to propofol.
Lower risk of low blood pressure and breathing issues was observed with ciprofol.
Patient comfort and safety may improve with ciprofol, especially in vulnerable groups.
Further research is recommended to confirm these findings in broader patient populations.
Citation: Hafez AA, Ahmed MS, Elfadali MA, Saadoun SE, Khairy AH, Hegazi A. Comparative efficacy and safety of ciprofol and propofol in hysteroscopy: A systematic review and meta-analysis of randomized controlled trials. Journal of Anaesthesiology Clinical Pharmacology. 2026;42(3):316-331. doi:10.4103/joacp.joacp_657_25.
